Hereditary angioedema is a rare genetic disorder characterized by recurrent and potentially life-threatening episodes of swelling. Growing disease awareness, improved diagnostic capabilities, and continued therapeutic innovation are expanding access to effective disease management worldwide. The Hereditary Angioedema Market is expected to grow from US$ 3.88 billion in 2025 to US$ 7.38 billion...